[ASAP] Discovery of Hydroxyamidine Based Inhibitors of IDO1 for Cancer Immunotherapy with Reduced Potential for Glucuronidation

ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.9b00572

Source: ACS Medicinal Chemistry Letters - January 27, 2020 Category: Chemistry Authors: Christoph Steeneck*, Olaf Kinzel, Simon Anderhub, Martin Hornberger, Sheena Pinto, Barbara Morschhaeuser, Floriane Braun, Gerald Kleymann, and Thomas Hoffmann Source Type: research